Within-host co-evolution of KPC variants: plasmid-mediated dissemination of <i>bla</i><sub>Kpc-194</sub> and <i>bla</i><sub>Kpc-33</sub> in ST11-KL64 hypervirulent <i>Klebsiella pneumoniae</i> driving ceftazidime-avibactam resistance. [PDF]
Ding L +8 more
europepmc +1 more source
Genomic characterization of ceftazidime/avibactam-resistant <i>Klebsiella pneumoniae</i>: a retrospective analysis on clinical isolates from an Italian transplant unit. [PDF]
Nicitra E +10 more
europepmc +1 more source
Antimicrobial Susceptibility of <i>Pseudomonas aeruginosa</i> from Elderly Patients in Intensive Care Units of United States Medical Centers (2021-2025). [PDF]
Sader HS +4 more
europepmc +1 more source
Integrated machine learning, molecular dynamics, and density functional theory approaches for identifying potential inhibitor targeting TEM 𝛽-lactamase in <i>Escherichia coli</i>. [PDF]
Roy A, Anbarasu A.
europepmc +1 more source
Unraveling Cefiderocol Resistance in NDM- and OXA-48-like Co-Producing <i>Klebsiella pneumoniae</i> Isolates Through Integrated Genomic and Phenotypic Analysis. [PDF]
Ambretti S +5 more
europepmc +1 more source
Co-Administration Dosing of Ceftazidime-Avibactam and Aztreonam in Patients with Varying Renal Function for Carbapenem-Resistant Enterobacterales Infections via Monte Carlo Simulation. [PDF]
Hemapanpairoa J +3 more
europepmc +1 more source
Current progress in antibacterial agents for carbapenem-resistant enterobacterales. [PDF]
Xu W +10 more
europepmc +1 more source
Synergistic Potential of Repurposing non-β-lactam Compounds as Class A serine β-lactamases Inhibitor: Insights from MolecularDocking, Molecular Dynamics Simulations and Antimicrobial Potentiation. [PDF]
Abdalla MS +11 more
europepmc +1 more source
The <i>bla<sub>KPC-249</sub></i> -mediated mechanism drives the transition of ST463 <i>Pseudomonas aeruginosa</i> from Ceftazidime-Avibactam sensitivity to resistance during clinical treatment. [PDF]
Li X +7 more
europepmc +1 more source

